<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">58914</article-id><article-id pub-id-type="doi">10.7554/eLife.58914</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>Effects of lifelong testosterone exposure on health and disease: a Mendelian randomization study</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-189380"><name><surname>Mohammadi-Shemirani</surname><given-names>Pedrum</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189376"><name><surname>Chong</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189377"><name><surname>Pigeyre</surname><given-names>Marie</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189378"><name><surname>Morton</surname><given-names>Robert W</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0099-4167</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-189379"><name><surname>Gerstein</surname><given-names>Hertzel C</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-187871"><name><surname>Paré</surname><given-names>Guillaume</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6795-4760</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Medical Sciences</institution>, <institution>McMaster University</institution>, <addr-line><named-content content-type="city">Hamilton</named-content></addr-line>, <country>Canada</country></aff><aff id="aff2"><institution content-type="dept">Biochemistry and Biomedical Sciences</institution>, <institution>McMaster University</institution>, <addr-line><named-content content-type="city">Hamilton</named-content></addr-line>, <country>Canada</country></aff><aff id="aff3"><institution content-type="dept">Medicine</institution>, <institution>McMaster University</institution>, <addr-line><named-content content-type="city">Hamilton</named-content></addr-line>, <country>Canada</country></aff><aff id="aff4"><institution content-type="dept">Kinesiology</institution>, <institution>McMaster University</institution>, <addr-line><named-content content-type="city">Hamilton</named-content></addr-line>, <country>Canada</country></aff><aff id="aff5"><institution content-type="dept">Pathology and Molecular Medicine</institution>, <institution>McMaster University</institution>, <addr-line><named-content content-type="city">Hamilton</named-content></addr-line>, <country>Canada</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-143776"><name><surname>Shoback</surname><given-names>Dolores</given-names></name><role>Reviewing editor</role><aff><institution>University of California, San Francisco</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>pareg@mcmaster.ca</email> (GP);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>16</day><month>10</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e58914</elocation-id><history><date date-type="received"><day>14</day><month>05</month><year>2020</year></date><date date-type="accepted"><day>13</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Mohammadi-Shemirani et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Mohammadi-Shemirani et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-58914-v1.pdf"/><abstract><p>Testosterone products are prescribed to males for a variety of possible health benefits, but causal effects are unclear. Evidence from randomized trials are difficult to obtain, particularly regarding effects on long-term or rare outcomes. Mendelian randomization analyses were performed to infer phenome-wide effects of free testosterone on 461 outcomes in 161,268 males from the UK Biobank study. Lifelong increased free testosterone had beneficial effects on increased bone mineral density, and decreased body fat; adverse effects on decreased HDL, and increased risks of prostate cancer, androgenic alopecia, spinal stenosis, and hypertension; and context-dependent effects on increased haematocrit and decreased C-reactive protein. No benefit was observed for type 2 diabetes, cardiovascular or cognitive outcomes. Mendelian randomization suggests benefits of long-term increased testosterone should be considered against adverse effects, notably increased prostate cancer and hypertension. Well-powered randomized trials are needed to conclusively address risks and benefits of testosterone treatment on these outcomes.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Award</award-id><principal-award-recipient><name><surname>Chong</surname><given-names>Michael</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>Post-Doctoral Fellowship</award-id><principal-award-recipient><name><surname>Morton</surname><given-names>Robert W</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009776</institution-id><institution>McMaster University</institution></institution-wrap></funding-source><award-id>E.J. Moran Campbell Internal Career Research Award</award-id><principal-award-recipient><name><surname>Pigeyre</surname><given-names>Marie</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009776</institution-id><institution>McMaster University</institution></institution-wrap></funding-source><award-id>McMaster-Sanofi Population Health Institute Chair in Diabetes Research and Care</award-id><principal-award-recipient><name><surname>Gerstein</surname><given-names>Hertzel C</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004351</institution-id><institution>Cisco Systems</institution></institution-wrap></funding-source><award-id>Professorship in Integrated Health Biosystems</award-id><principal-award-recipient><name><surname>Paré</surname><given-names>Guillaume</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001804</institution-id><institution>Canada Research Chairs</institution></institution-wrap></funding-source><award-id>Canada Research Chair in Genetic and Molecular Epidemiology</award-id><principal-award-recipient><name><surname>Paré</surname><given-names>Guillaume</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Hertzel C Gerstein, HCG reports research grants from Eli Lilly, AstraZeneca, Merck, Novo Nordisk, and Sanofi; honoraria for speaking from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, and Sanofi; and consulting fees from Abbott, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck, Novo Nordisk, Janssen, Sanofi, Kowa, and Cirius..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: UK Biobank received ethical approval from the North West Multi-Centre Research Ethics Committee (REC reference: 11/NW/0382). This research was conducted using the UK Biobank under Application Number 15255.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Individual-level data cannot be provided, but it is available to all researchers by application to the UK Biobank. Summary-level GWAS data will be returned to the UK Biobank Access Team for use by other researchers. All MR results and genome-wide significant SNPs have been provided in Supplementary Tables 4 to 12.</p></sec><supplementary-material><ext-link xlink:href="elife-58914-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>